Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

NCT07527650 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
T2DM

Interventions

DRUG: HM15275
DRUG: Placebo of HM15275

Sponsor

Hanmi Pharmaceutical Company Limited